Oncovita announces a strategic partnership with Infinitusbio.AI to explore the design and optimize the development of new therapeutic candidates from its Measovir(R) platform.

January 12, 2026. Infinitusbio.AI, a U.S.-based Pharmatech company and creator of the proprietary Simulative AI Digital Cell Clone platform, and Oncovita, a Paris-based biotechnology company spun out ...

Sneak peek at National Zoo's new Arabian leopard habitat

The zoo's partnership with Saudi Arabia's Royal Commission aims to create a conservation program similar to the zoo's ...

India's 60 million street dogs are turning from village scavengers to city territory defenders

Growing up in rural India, my grandmother would feed the village dog half a chapati and a bowl of milk each afternoon, surely ...
MassDevice

Vicarious Surgical moves toward surgical robot design freeze following successful animal lab

Vicarious Surgical (NYSE:RBOT) announced today that it successfully completed an in-vivo porcine lab as it advances its ...
TMCnet

Vicarious Surgical Advances Toward Design Freeze with Successful In-Vivo Porcine Lab

The December in-vivo lab builds on Vicarious Surgical's disciplined, specification-driven development approach and reflects the company's focus on minimizing technical risk through iterative testing, ...